•  103
    Reflecting on Principlism: Explaining, But Not Guiding, Clinical Ethics Analysis
    American Journal of Bioethics 26 (3): 19-25. 2026.
    Tom Beauchamp’s contributions to the field of bioethics are as influential as they are numerous. Here we reflect on his intellectual legacy, specifically his role in establishing principlism as a method of bioethical analysis. Despite its prominence in medical ethics education, in our experience as clinical ethicists and researchers, we rarely analyze ethical issues the way principlism suggests, either in the clinic or our scholarship. In this paper, we consider the complex ways in which princip…Read more
  •  45
    Keeping Fellows in the Frame: The Importance of Including Clinical Ethics Fellows in Fellowship Standardization
    with Megan Kitts, Tara Finnegan, Alexander Gariti, and Callie Terris
    American Journal of Bioethics 25 (10): 80-82. 2025.
    In “Clinical Ethics Fellowship Programs in the U.S. and Canada,” Fox and Wasserman (2025) establish a descriptive baseline of clinical ethics fellowship programs (CEFPs) aimed at informing future s...
  •  68
    Should Physicians Take the Rap? Normative Analysis of Clinician Perspectives on Responsible Use of ‘Black Box’ AI Tools
    with Ben H. Lang, Kristin Kostick-Quenet, Meghan Hurley, Rita Dexter, and Jennifer Blumenthal-Barby
    AJOB Empirical Bioethics 16 (4): 201-212. 2025.
    Background Increasing interest in deploying artificial intelligence tools in clinical contexts has raised several ethical questions of both normative and empirical interest. One such question in the literature is whether “responsibility gaps” (r-gaps) are created when clinicians utilize or rely on such tools for providing care, and if so, what to do about them. These gaps are particularly likely to arise when using opaque, “black box” AI tools. Compared to normative and legal analysis of AI-gene…Read more
  •  95
    It is increasingly common for bioethicists to consult with the public to solicit their judgments and attitudes about ethical questions and issues, especially ones that arise with new and emerging technologies. However, it is not always clear what the purpose of this engagement is or ought to be: do bioethicists seek the input of the public to help them arrive at a morally correct justified policy position, or do they seek this input to help them shape and frame their already-established moral po…Read more
  •  109
    Patient Consent and The Right to Notice and Explanation of AI Systems Used in Health Care
    with Meghan E. Hurley, Benjamin H. Lang, Kristin Marie Kostick-Quenet, and Jennifer Blumenthal-Barby
    American Journal of Bioethics 25 (3): 102-114. 2024.
    Given the need for enforceable guardrails for artificial intelligence (AI) that protect the public and allow for innovation, the U.S. Government recently issued a Blueprint for an AI Bill of Rights which outlines five principles of safe AI design, use, and implementation. One in particular, the right to notice and explanation, requires accurately informing the public about the use of AI that impacts them in ways that are easy to understand. Yet, in the healthcare setting, it is unclear what goal…Read more
  •  47
    Deep Brain Stimulation for Childhood Treatment-Resistant Obsessive-Compulsive Disorder: Mental Health Clinician Views on Candidacy Factors
    with Ilona Cenolli, Tiffany A. Campbell, Natalie Dorfman, Meghan Hurley, Kristin Kostick-Quenet, Eric A. Storch, Jennifer Blumenthal-Barby, and Gabriel Lázaro-Muñoz
    AJOB Empirical Bioethics 16 (1): 32-41. 2025.
    Introduction Deep brain stimulation (DBS) is approved under a humanitarian device exemption to manage treatment-resistant obsessive-compulsive disorder (TR-OCD) in adults. It is possible that DBS may be trialed or used clinically off-label in children and adolescents with TR-OCD in the future. DBS is already used to manage treatment-resistant childhood dystonia. Evidence suggests it is a safe and effective intervention for certain types of dystonia. Important questions remain unanswered about th…Read more
  •  57
    Co-Reasoning in Context: Collaboration in Critical Care
    with Ben H. Lang and Meghan E. Hurley
    American Journal of Bioethics 24 (9): 100-102. 2024.
    In “What are Humans Doing in the Loop?” Salloch and Eriksen (2024) argue for a collaborative decision-making approach to using machine learning-based AI decisional support systems in medicine, rece...
  •  82
    From Opioid Overdose to LVAD Refusals: Navigating the Spectrum of Decisional Autonomy
    with Jennifer Blumenthal-Barby, Ben H. Lang, and Joanna Smolenski
    American Journal of Bioethics 24 (5): 8-10. 2024.
    In “Revive and Refuse: Capacity, Autonomy, and Refusal of Care After Opioid Overdose”, Marshall, Derse, Weiner, and Joseph contend that patients who may appear to satisfy the standard criteria for...
  •  78
    Adolescent OCD Patient and Caregiver Perspectives on Identity, Authenticity, and Normalcy in Potential Deep Brain Stimulation Treatment
    with Natalie Dorfman, Meghan Hurley, Ilona Cenolli, Kristin Kostick-Quenet, Eric A. Storch, Gabriel Lázaro-Muñoz, and Jennifer Blumenthal-Barby
    Cambridge Quarterly of Healthcare Ethics 33 (4): 507-520. 2024.
    The ongoing debate within neuroethics concerning the degree to which neuromodulation such as deep brain stimulation (DBS) changes the personality, identity, and agency (PIA) of patients has paid relatively little attention to the perspectives of prospective patients. Even less attention has been given to pediatric populations. To understand patients’ views about identity changes due to DBS in obsessive-compulsive disorder (OCD), the authors conducted and analyzed semistructured interviews with a…Read more
  •  1147
    The Lived Realities of Chemical Restraint: Prioritizing Patient Experience
    American Journal of Bioethics Neuroscience 15 (1): 29-31. 2024.
    In The Conditions for Ethical Chemical Restraint, Crutchfield and Redinger (2024) propose ethical standards for the use of chemical restraints, which they consider normatively distinct from physica...
  •  95
    The Moral Psychology of Obsessive-Compulsive Disorder
    Dissertation, University of California, Riverside. 2022.
    Imagine a person with a compulsive illness that leads her to frequently wash her hands. She will scrub her hands under all sorts of bizarre conditions, such as seeing a garbage truck drive down the road or hearing the word ‘trash’ on television. Sometimes her hands do need to be cleaned but this is usually a fortunate coincidence. This person does not have control over her behavior because she cannot help herself from washing her hands (unless dire consequences were to follow, such as the th…Read more
  •  172
    Trust criteria for artificial intelligence in health: normative and epistemic considerations
    with Kristin Kostick-Quenet, Benjamin H. Lang, Meghan Hurley, and Jennifer Blumenthal-Barby
    Journal of Medical Ethics 50 (8): 544-551. 2024.
    Rapid advancements in artificial intelligence and machine learning (AI/ML) in healthcare raise pressing questions about how much users should trust AI/ML systems, particularly for high stakes clinical decision-making. Ensuring that user trust is properly calibrated to a tool’s computational capacities and limitations has both practical and ethical implications, given that overtrust or undertrust can influence over-reliance or under-reliance on algorithmic tools, with significant implications for…Read more
  •  142
    Perspectives on informed assent and bodily integrity in prospective deep brain stimulation for youth with refractory obsessive-compulsive disorder
    with Natalie Dorfman, Meghan Hurley, Ilona Cenolli, Kristin Kostick-Quenet, Gabriel Lazaro-Munoz, Eric A. Storch, and Jennifer Blumenthal-Barby
    Clinical Ethics 19 (4): 297-306. 2024.
    Background Deep brain stimulation is approved for treating refractory obsessive-compulsive disorder in adults under the US Food and Drug Administration Humanitarian Device Exemption, and studies have shown its efficacy in reducing symptom severity and improving quality of life. While similar deep brain stimulation treatment is available for pediatric patients with dystonia, it is not yet available for pediatric patients with obsessive-compulsive disorder, although soon could be. The prospect of …Read more
  •  88
    In ‘Patients, doctors and risk attitudes,’ Makins argues that, when physicians must decide for, or act on behalf of, their patients they should defer to patient risk attitudes for many of the same reasons they defer to patient values, although with a caveat: physicians should defer to the higher-order desires of patients when considering their risk attitudes. This modification of what Makins terms the ‘deference principle’ is primarily driven by potential counterexamples in which a patient has a…Read more
  •  85
    Therapeutic Artificial Intelligence: Does Agential Status Matter?
    with Meghan E. Hurley and Benjamin H. Lang
    American Journal of Bioethics 23 (5): 33-35. 2023.
    In their paper, “Conversational Artificial Intelligence in Psychotherapy: A New Therapeutic Tool or Agent?” Sedlakova and Trachsel (2023) claim that therapeutic insights and therapeutic changes are...
  •  56
    Call for moral recognition as part of paediatric assent
    with Jennifer Blumenthal-Barby
    Journal of Medical Ethics 49 (7): 481-482. 2023.
    In ‘Reification and Assent in Research Involving Those Who Lack Capacity’, Smajdor argues that adults with impaired capacity to grant informed consent (AWIC) are often excluded from participating in biomedical research because they cannot provide informed consent, leading to decreased chances AWIC will benefit from such research. Smajdor uses Honneth’s concept of reification to propose that securing assent (rather than consent) in cases involving AWIC offers patients moral recognition that is no…Read more